2Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology ( ESC), European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope ( version 2009) [ J ]. Eur Heart J, 2009,30 ( 21 ) : 2631-2671.
3Sheldon R S, Morillo C A, Krahn A D, et al. Standard- ized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper [ J ]. Can J Cardiol, 2011,27 (2) :246-253.
4Task Force for the Diagnosis and Management of Syncope,European Society of Cardiology (ESC),European Heart Rhythm Association (EHRA). Guidelines for the diagnosis and management of syncope (version 2009)[J].European Heart Journal,2009.2631-2671.
5Barsheshet A,Moss AJ,McNitt S. Risk of Syncope in Family Members Who Are Genotype Negative for a Family-Associated Long QT Syndrome Mutation[J].Circ Cardiovasc Genet,2011.491-499.
6Brignole M,Deharo JC,De Roy L. Syncope due to idiopathic paroxysmal atrioventricular block:long-term follow-up of a distinct form of atrioventricular block[J].Journal of the American College of Cardiology,2011.167-173.
7Liu JF,Jons C,Moss AJ. Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents With Long QT Syndrome[J].Journal of the American College of Cardiology,2011.941-950.
8Liu J,Fang P,Liu Y. Duration of head-up tilt test for patients with suspected vasovagal syncope[J].Europace:European Pacing,Arrhythmias and Cardiac Electrophysiology,2011.576-580.
9Kühne M,Schaer B,Sticherling C. Holter monitoring in syncope:diagnostic yield in octogenarians[J].Journal of the American Geriatrics Society,2011.1293-1298.
10Parry SW,Matthews IG. Implantable loop recorders in the investigation of unexplained syncope:a state of the art review[J].Heart,2010.1611-1616.
5Chen Scarabelli C, Kaza A R, Scarabel|i T, et al. Syn- cope due to nasopharyngeal carcinoma[ J]. Lancet Oncol, 2005,6 ( 5 ) : 347-349.
6Tulchinsky M, Krasnow S H. Carotid sinus syndrome as- sociated with an occult primary nasopharyngeal carcinoma [J]. Arch Intern Med, 1985,148(5) :1217-1219.
7Tang Y, Wang J M, Huang C H. Syncope in nasopharyn- geal carcinoma: report of three cases and review of the lit- erature[ J]. Changgeng Yi Xue Za Zhi, 1993,16( 1 ) :59- 65.
8Brignole M, Ungar A, Casagranda I, et al. P prospective multicentre systematic guideline- based management of patients referred to the syncope units of general hospitals [ J ]. Europace, 2010,12 ( 1 ) : 109-118.
9Ju J H, Kang M H, Kim H G, et al. Successful treat- ment of syncope with chemotherapy irresponsive to cardiac pacemaker in head and neck cancer [ J ]. Yonsei Med J, 2009,50 ( 5 ) : 725 -728.
10Raj SR, Faris PD, Semeniuk L, et al. Rationale for the Assess- ment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5) [ J ]. Am Heart J, 2016,174:89-94.
